Shares of FibroGen fell by a staggering 56.81% in 30 days from $-36.9 to $19.91 at 19:13 EST on Friday, following last session’s upward trend. NASDAQ Composite is jumping 1.31% to $14,038.76, following last session’s upward trend, This seems, up to now, an all-around positive trend trading session today.
FibroGen’s last close was $19.30, 187.34% under its 52-week high of $57.21.
The company’s growth estimates for the current quarter and the next is 10.1% and 68.4%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $19.91 at 19:13 EST, way below its 52-week high of $57.21 and higher than its 52-week low of $19.11.
FibroGen’s Moving Average
FibroGen’s value is way below its 50-day moving average of $39.14 and way under its 200-day moving average of $42.31.
More news about FibroGen.